#1
#1 out of 1
health19h ago
Where do Europeans wait longest for new medicines?
- EU medicines reach users in a median of 532 days after market authorisation, with wide country gaps.
- Germany delivers medicines 56 days after authorisation, while Romania waits 1,201 days.
- Public reimbursement coverage declined from 42% in 2019 to 28% in 2025, limiting access.
- The share of medicines fully available on reimbursement fell to 28% across Europe by 2025.
- EFPIA tracked 168 innovative medicines approved 2021–2024; Germany led market presence.
- EFPIA warns Europe lags regulatory-wise behind the United States.
- EU countries show uneven access to innovative therapies and orphan drugs.
- The report highlights regional disparities, with Northern/Western Europe generally faster than Southern/Eastern Europe.
- EFPIA's quarterly tracker compares US approvals with EMA and Chinese NMPA.
- EFPIA notes that regulatory speed differences affect patient access across regions.
- The study covers medicines authorised between 2021 and 2024 across the EU.
Vote 0